Caren Deardorf has officially reported ownership of shares in Alpha Cognition Inc., a company engaged in the biological products sector. This filing is significant as it underscores the importance of transparency in executive ownership and may have implications for the company's future strategies.

Background

Deardorf Caren is associated with Alpha Cognition Inc., which operates under the Central Index Key 0001655923. The company is classified under the SIC code for Biological Products (No Diagnostic Substances) [2836]. Recent filings include a Form 4 on November 13, 2026, and a Form 3 on the same date, indicating active reporting of ownership changes.

What the Filing Says

The filing states that Deardorf Caren is a director at Alpha Cognition Inc. and has reported ownership of one security as of November 11, 2026. The filing emphasizes the importance of accurate reporting in maintaining investor confidence.

Impact

This change may affect shareholders and stakeholders within Alpha Cognition Inc., as it reflects the commitment of its directors to transparency and accountability. Such ownership disclosures can influence investor sentiment and market perception of the company's governance practices.

What's Next

The filing does not say what happens next.

Details of the Filing

The filing specifies that Caren Deardorf holds one security in Alpha Cognition Inc. as of November 11, 2026. This security ownership is part of her role as a director, which is a position that entails significant responsibilities and fiduciary duties to the shareholders.

Company Information

Alpha Cognition Inc. operates under the Central Index Key 0001655923 and is classified under the SIC code for Biological Products (No Diagnostic Substances) [2836]. The company is incorporated in the state of A1 and has its fiscal year ending on December 31. The business address is located at 1452 Hughes Rd., Suite 200, Grapevine, TX 76051, with a contact phone number of (858) 344-4375.

Previous Company Name

It is noteworthy that Alpha Cognition Inc. was formerly known as Neurodyn Cognition Inc., a name change that took effect on October 16, 2015. This rebranding may reflect a strategic shift or a new direction for the company in the biological products sector.

Filing Context

The filing does not provide additional context regarding the motivations behind the ownership change, nor does it detail any future plans or strategies that may be influenced by this disclosure.